Hospitalization at Home: The Acute Care Home Hospital Program for Adults

July 7, 2017 updated by: Jeffrey L. Schnipper, MD.,MPH., Brigham and Women's Hospital

Hospitalization at Home Pilot: The Acute Care Home Hospital Program for Adults

The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and improved patient experience.

Study Overview

Detailed Description

Hospitals are the standard of care for acute illness in the United States, but hospital care is expensive and often unsafe, especially for older individuals. While admitted, 20% suffer delirium, over 5% contract hospital-acquired infections, and most lose functional status that is never regained. Timely access to inpatient care is poor: many hospital wards are typically over 100% capacity, and emergency department waits can be protracted. Moreover, hospital care is increasingly costly: many internal medicine admissions have a negative margin (i.e., expenditures exceed hospital revenues) and incur patient debt.

The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, 20% reduced cost, and 20% improved patient experience. While this is the standard of care in several developed countries, only 2 non-randomized demonstration projects have been conducted in the United States, each with highly local needs. Taken together, home hospital evidence is promising but falls short due to non-robust experimental design, failure to implement modern medical technology, and poor enlistment of community support.

The home hospital module offers most of the same medical components that are standard of care in an acute care hospital. The typical staff (medical doctor [MD], registered nurse [RN], case manager), diagnostics (blood tests, vital signs, telemetry, x-ray, and ultrasound), intravenous therapy, and oxygen/nebulizer therapy will all be available for home hospital. Optional deployment of food services, home health aide, physical therapist, occupational therapist, and social worker will be tailored to patient need. Home hospital improves upon the components of a typical ward's standard of care in several ways:

  • Point of care blood diagnostics (results at the bedside in <5 minutes);
  • Minimally invasive continuous vital signs, telemetry, activity tracking, and sleep tracking;
  • On-demand 24/7 clinician video visits;
  • 4 to 1 patient to MD ratio, compared to typical 16 to 1;
  • Ambulatory/portable infusion pumps that can be worn on the hip;
  • Optional access to a personal home health aide

Should a matter be emergent (that is, requiring in-person assistance in less than 20 minutes), then 9-1-1 will be called and the patient will be returned to the hospital immediately. In previous iterations of home hospital this happens in about 2% of patients.

Clinical parameters measured will be at the discretion of the physician and nurse, who treat the participant following evidence-based practice guidelines, just as in the usual care setting. In addition, the investigators will be tracking a wide variety of measures of quality and safety, including some measures tailored to each primary diagnosis.

Study Type

Interventional

Enrollment (Actual)

21

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02120
        • Brigham and Women's Hospital
      • Boston, Massachusetts, United States, 02130
        • Brigham and Women's Faulkner Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Resides within 5-mile radius of emergency room
  • English- or Spanish-speaker
  • Can identify a potential caregiver who agrees to stay with patient for first 24 hours of admission. Caregiver must be competent to call care team if a problem is evident to her/him.
  • This criterion may be waived for highly competent patients at the patient and clinician's discretion.
  • >=18 years old
  • Primary diagnosis of cellulitis, heart failure, complicated urinary tract infection, or pneumonia that requires inpatient admission as determined by blinded emergency room team.

Exclusion Criteria:

  • Undomiciled
  • No working heat (October-April), no working air conditioning if forecast > 80°F (June-September), or no running water
  • On methadone requiring daily pickup of medication
  • In police custody
  • Resides in facility that provides on-site medical care (e.g., skilled nursing facility)
  • Domestic violence screen positive
  • Cared for by a private primary care physician who rounds in the hospital
  • Cannot establish peripheral access in emergency department (or access requires ultrasound guidance)
  • Secondary condition: active non-melanoma/prostate cancer, end-stage renal disease, acute myocardial infarction, acute cerebral vascular accident, acute hemorrhage
  • Primary diagnosis requires narcotics for pain control
  • Cannot independently ambulate to bedside commode
  • As deemed by on-call medical doctor, patient likely to require any of the following procedures: computed tomography, magnetic resonance imaging, endoscopic procedure, blood transfusion, cardiac stress test, or surgery
  • For pneumonia:
  • Most recent CURB65 > 3: new confusion, blood urea nitrogen > 19mg/dL, respiratory rate>=30/min, systolic blood pressure<90mmHg, Age>=65
  • Most recent SMRTCO > 2: systolic blood pressure < 90mmHg (2pts), multilobar chest xray involvement (1pt), respiratory rate >= 30/min, heart rate >= 125, new confusion, oxygen saturation <= 90%
  • Absence of clear infiltrate on imaging
  • Cavitary lesion on imaging
  • O2 saturation < 90% despite 5L O2
  • For heart failure:
  • Has a left ventricular assist device or paced rhythm
  • Get with the Guidelines - Heart Failure (>10% in-hospital mortality) or The Acute Decompensated Heart Failure National Registry score (high risk or intermediate risk 1)
  • Anasarca
  • Pulmonary hypertension
  • For complicated urinary tract infection:
  • Absence of pyuria
  • Most recent quick sepsis related organ failure assessment > 1
  • Home hospital census is full (maximum 4 patients at any time)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Inpatient hospitalization
Control / usual care arm. Patients are admitted per usual to an inpatient service. Patients' medical records will be closely monitored. Patients will wear a vitals and activity monitor whose data is used only retrospectively. On discharge and 30 days after discharge, they will be interviewed regarding their hospitalization and health.
Experimental: Home hospitalization
Intervention arm. Patients will return home after triage, diagnosis, and the beginning of treatment in the emergency department with a set of specialized patient-tailored services (listed above). On discharge and 30 days after discharge, they will be interviewed regarding their hospitalization and health.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Total cost of hospitalization, $
Time Frame: Day of admission to day of discharge
Day of admission to day of discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Direct margin, $
Time Frame: Day of admission to day of discharge
Direct margin from total cost of hospitalization
Day of admission to day of discharge
Direct margin, modeled with backfill, $
Time Frame: Day of admission to day of discharge
Backfill uses a model that estimates the cost of patients who take the place of home hospital patients
Day of admission to day of discharge
Length of stay, days
Time Frame: Day of admission to day of discharge
Day of admission to day of discharge
Imaging, #
Time Frame: Day of admission to day of discharge
Day of admission to day of discharge
Lab Orders, #
Time Frame: Day of admission to day of discharge
Day of admission to day of discharge
Discharge Disposition
Time Frame: Day of discharge
Routine, skilled nursing facility, home health, other
Day of discharge
Readmission(s) after index hospitalization, y/n
Time Frame: Day of discharge to 30 days later
Dichotomous outcome
Day of discharge to 30 days later
Time to readmission after index hospitalization, days
Time Frame: Day of discharge to 30 days later
Survival curve (hazard analysis)
Day of discharge to 30 days later
Emergency Department (ED) observation stay(s) after index hospitalization, y/n
Time Frame: Day of discharge to 30 days later
Dichotomous outcome
Day of discharge to 30 days later
Time to ED observation stay(s) after index hospitalization, days
Time Frame: Day of discharge to 30 days later
Survival curve (hazard analysis)
Day of discharge to 30 days later
ED visit(s) after index hospitalization, y/n
Time Frame: Day of discharge to 30 days later
Dichotomous outcome
Day of discharge to 30 days later
Time to ED visit(s) after index hospitalization, days
Time Frame: Day of discharge to 30 days later
Survival curve (hazard analysis)
Day of discharge to 30 days later
Delirium, y/n
Time Frame: Day of admission to day of discharge
Day of admission to day of discharge
Transfer back to hospital, y/n
Time Frame: Day of admission to day of discharge
intervention arm only
Day of admission to day of discharge
Hours of sleep, #
Time Frame: Day of admission to day of discharge
Day of admission to day of discharge
Daily steps, #
Time Frame: Day of admission to day of discharge
Day of admission to day of discharge
EuroQol -5D-5L, composite score
Time Frame: At admission, at discharge, and at 30 days after discharge
At admission, at discharge, and at 30 days after discharge
Short Form 1
Time Frame: 30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
1-5 Likert scale
30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
Activities of daily living, score
Time Frame: 30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
Instrumental activities of daily living, score
Time Frame: 30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
3-item Care Transition Measure, score
Time Frame: 30 days after discharge
30 days after discharge
Picker Experience Questionnaire, score
Time Frame: 30 days after discharge
30 days after discharge
Global satisfaction with care, score
Time Frame: 30 days after discharge
30 days after discharge
Qualitative interview
Time Frame: 30 days after discharge
30 days after discharge

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total cost of episode of care, $
Time Frame: Day of admission to 30 days after discharge
Exploratory; Subset of sample for which claims data is available
Day of admission to 30 days after discharge
Intraveneous medications, days
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Intraveneous fluids, days
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Intraveneous diuretics, days
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Intraveneous antibiotics, days
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Supplemental oxygen required, days
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Nebulizer treatment, days
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Medical Doctor sessions, # notes
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Consultant sessions, # notes
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Physical therapy/occupational therapy sessions, # notes
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Primary care provider follow-up within 14 days, y/n
Time Frame: Day of discharge to 14 days later
Exploratory
Day of discharge to 14 days later
Skilled nursing facility utilization, days
Time Frame: Day of discharge to 30 days later
Exploratory
Day of discharge to 30 days later
Home health utilization, days
Time Frame: Day of discharge to 30 days later
Exploratory
Day of discharge to 30 days later
Fall, y/n
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Diagnosis of hospital-acquired or post-discharge deep vein thrombosis or pulmonary embolism
Time Frame: Day of admission to 30 days after discharge
Exploratory
Day of admission to 30 days after discharge
Hospital-acquired pressure ulcer, y/n
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Thrombophlebitis at peripheral intravenous site, y/n
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Catheter-associated urinary tract infection, y/n
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Clostridium difficile infection, y/n
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Methicillin resistant staph aureus infection, y/n
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Mortality during admission, y/n
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Post-discharge mortality, y/n
Time Frame: Day of discharge to 30 days later
Exploratory
Day of discharge to 30 days later
New arrhythmia, y/n
Time Frame: Day of admission to day of discharge
Heart failure patients only; Exploratory
Day of admission to day of discharge
Hypokalemia, y/n
Time Frame: Day of admission to day of discharge
Heart failure patients only; Exploratory
Day of admission to day of discharge
Acute kidney injury, y/n
Time Frame: Day of admission to day of discharge
Heart failure patients only; Exploratory
Day of admission to day of discharge
Mean Likert scale pain score, 0-10
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Pneumococcal vaccination if appropriate, y/n
Time Frame: Day of admission to day of discharge
Pneumonia patients only; Exploratory
Day of admission to day of discharge
Influenza vaccination if appropriate, y/n
Time Frame: Day of admission to day of discharge
Pneumonia patients only; Exploratory
Day of admission to day of discharge
Smoking cessation counseling if appropriate, y/n
Time Frame: Day of admission to day of discharge
Pneumonia and heart failure patients only; Exploratory
Day of admission to day of discharge
Evaluation of ejection fraction as assessed by echocardiogram or other appropriate study, scheduled or completed, if not done within 1 year; y/n
Time Frame: Day of admission to day of discharge
Heart failure patients only; Exploratory; appropriate studies include cardiac magnetic resonance imaging, radionuclide ventriculography, single photon emission computed tomography myocardial perfusion imaging, or left ventriculography
Day of admission to day of discharge
Angiotensin converting enzyme inhibitor or angiotensin receptor blocker for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n
Time Frame: Day of admission to day of discharge
Heart failure patients only; Exploratory
Day of admission to day of discharge
Beta blocker for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n
Time Frame: Day of admission to day of discharge
Heart failure patients only; Exploratory
Day of admission to day of discharge
Aldosterone antagonist for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n
Time Frame: Day of admission to day of discharge
Heart failure patients only; Exploratory
Day of admission to day of discharge
Lipid lowering for coronary artery disease, peripheral vascular disease, cerebrovascular accident, or diabetes, y/n
Time Frame: Day of admission to day of discharge
Heart failure patients only; Exploratory
Day of admission to day of discharge
Smoking status post-discharge
Time Frame: 30 days after day of discharge
Heart failure and pneumonia patients only; Exploratory; current/never/quit.
30 days after day of discharge
Use of inappropriate medications in the elderly, y/n
Time Frame: Day of admission to day of discharge
Exploratory; using Screening Tool of Older Persons' potentially inappropriate Prescriptions (STOPP) and Beers criteria
Day of admission to day of discharge
Use of Foley catheter, y/n
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Use of restraints, y/n
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
>3 medications added to medication list, y/n
Time Frame: Day of discharge (compared with preadmission med list)
Exploratory
Day of discharge (compared with preadmission med list)
Patient health questionnaire-2, score
Time Frame: 30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
Exploratory
30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
Patient-Reported Outcomes Measurement Information System Emotional Support Short Form 4a, score
Time Frame: 30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
Exploratory
30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
Walk around ward/home, y/n
Time Frame: Day of discharge
Exploratory
Day of discharge
Get to (non-commode) bathroom, y/n
Time Frame: Day of discharge
Exploratory
Day of discharge
Walk 1 flight of stairs, y/n
Time Frame: Day of discharge
Exploratory
Day of discharge
Visit with friends/family, y/n
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Walk outside around my home, y/n
Time Frame: 30 days after discharge
Exploratory
30 days after discharge
Go shopping, y/n
Time Frame: 30 days after discharge
Exploratory
30 days after discharge
Time from admission decision to assessment by research assistant, minutes
Time Frame: Day of admission
Exploratory
Day of admission
Time from research assistant assessment to emergency department dismissal, minutes
Time Frame: Day of admission
Exploratory
Day of admission
Time from arrival home or to floor and medical doctor evaluation, minutes
Time Frame: Day of admission
Exploratory
Day of admission
Time from arrival home or to floor and registered nurse evaluation, minutes
Time Frame: Day of admission
Exploratory
Day of admission
Average Registered nurse to patient ratio
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Number of registered nurse visits, total
Time Frame: Day of admission to day of discharge
Exploratory
Day of admission to day of discharge
Number of "on call" medical doctor interactions (video or phone), total
Time Frame: Day of admission to day of discharge
Exploratory, intervention arm only
Day of admission to day of discharge
Number of "on call" medical doctor in-person visits, total
Time Frame: Day of admission to day of discharge
Exploratory, intervention arm only
Day of admission to day of discharge
Duration of 1st registered nurse visit, minutes
Time Frame: Day of admission
Exploratory, intervention arm only
Day of admission
Average Duration of subsequent registered nurse visit, minutes
Time Frame: Day of admission to day of discharge
Exploratory, intervention arm only
Day of admission to day of discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2016

Primary Completion (Actual)

December 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

August 3, 2016

First Submitted That Met QC Criteria

August 9, 2016

First Posted (Estimate)

August 12, 2016

Study Record Updates

Last Update Posted (Actual)

July 11, 2017

Last Update Submitted That Met QC Criteria

July 7, 2017

Last Verified

July 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

Clinical Trials on Inpatient Hospitalization

3
Subscribe